Oracle’s stock has come well off its highs, but a Jefferies analyst says concentration and debt concerns are overblown.

Logitech disclosed a data breach shortly after it was named as a victim of the recent Oracle’s E-Business Suite (EBS) hack.

Internal financial documents suggest that Oracle's GPU deals with the likes of OpenAI and other customers saw an average gross profit margin of just 16 percent. As reported by The Information, citing ...

Oracle Corp. shares fell almost 7 per cent on Tuesday following a report that the profit margin in its cloud computing segment is lower than what many on Wall Street had estimated. During the three ...

Cloud operator Oracle (ORCL) reported a $100 million loss from renting out its Nvidia (NVDA) Blackwell chips in its most recent quarter, according to a report from The Information. Oracle stock is ...

Oracle (ORCL) , the multi-billion-dollar cloud applications and platform service provider, is again in the news, for negative cash flow and a new $15 billion bond sale to fund its AI ambitions. In ...

Oracle stock has gained 86% year-to-date. In its fiscal year Q1 2026 report, Oracle missed the mark on GAAP EPS, down 2%. The company’s free cash flow also showed a 152% decline year over year, ...

Oracle (NYSE:ORCL) stock slipped after it moved to raise $15 billion in the U.S. investment-grade bond market on Wednesday, according to people familiar with the transaction. The company offers debt ...

Meta is in talks to sign a multi-year cloud deal with Oracle worth about $20 billion, Reuters reports. The contract would be used to augment Meta's growing AI training and inference needs. Meta has ...

Oracle (NYSE:ORCL) was up around 3.5% premarket on Tuesday on a CBS report that it was part of a consortium looking to keep TikTok operating in the U.S. under a possible framework deal between China ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp. (ORCL), AstraZeneca PLC ...